NEJM This Week: Supplement to the New England Journal of Medicine, Vol. 361, No. 13. Episode | New England Journal of Medicine (NEJM) Audio Summaries
Primary Format :ScienceAlso Listed as:User Tags:User Votes:RSS FeedWebsite Visit Trumix.com for the most recent listings of: NEJM This Week: Supplement to the New England Journal of Medicine, Vol. 361, No. 13.
User Tags:User Votes:RSS FeedWebsite
User Votes:RSS FeedWebsite
RSS FeedWebsite
Visit Trumix.com for the most recent listings of:
NEJM This Week: Supplement to the New England Journal of Medicine, Vol. 361, No. 13.
Play Now -->DATE : Wed, 23 Sep 2009 10:18:14 -0400Entered in Database : 2009-09-23 14:18:14length : 10307886 Link to the Show / Show Notes This summary covers the issue of September 24, 2009. Featured are articles on daunorubicin for acute myeloid leukemia in older patients, anthracycline dose intensification in AML, comparative efficacy of inactivated and live attenuated influenza vaccines, a double-blind, delayed-start trial of rasagiline in Parkinson's disease, the delayed-start study design, interferon-alpha; and the treatment of leukemia; a review article on renal failure in cirrhosis; a case report of a man with recurrent transitional-cell carcinoma of the ureter; and Perspective articles on doctors as the key to health care reform, on the high cost of health care in the United States, and on incorporating comparative-effectiveness information into FDA labeling. Play in your Iphone
This summary covers the issue of September 24, 2009. Featured are articles on daunorubicin for acute myeloid leukemia in older patients, anthracycline dose intensification in AML, comparative efficacy of inactivated and live attenuated influenza vaccines, a double-blind, delayed-start trial of rasagiline in Parkinson's disease, the delayed-start study design, interferon-alpha; and the treatment of leukemia; a review article on renal failure in cirrhosis; a case report of a man with recurrent transitional-cell carcinoma of the ureter; and Perspective articles on doctors as the key to health care reform, on the high cost of health care in the United States, and on incorporating comparative-effectiveness information into FDA labeling.
Play in your Iphone